(Q37237986)

19 August 2017

Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I (English)

1 reference

19 August 2017

1 reference

1 reference

1 reference

4

Isenberg DA

1 reference

19 August 2017

Keeling DM

1

1 reference

19 August 2017

Wilson AJ

series ordinal

2

1 reference

19 August 2017

Mackie IJ

series ordinal

3

1 reference

19 August 2017

Machin SJ

series ordinal

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 July 1993

1 reference

Journal of Clinical Pathology

19 August 2017

1 reference

19 August 2017

46

1 reference

19 August 2017

7

1 reference

19 August 2017

665-667

1 reference

The 1982 revised criteria for the classification of systemic lupus erythematosus

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501399

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501399

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501399

Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501399

Immunological specificity and mechanism of action of IgG lupus anticoagulants

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501399

Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501399

Lupus-like anticoagulant properties of murine monoclonal antibodies to beta 2-glycoprotein I

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501399

Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid

26 June 2018

1 reference

12 December 2020

Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986

1 reference

12 December 2020

Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column

1 reference

12 December 2020

Purification of antiphospholipid antibodies using a new affinity method

1 reference

12 December 2020

Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies

1 reference

12 December 2020

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

12 December 2020

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

12 December 2020

Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin

1 reference

12 December 2020

Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.46.7.665

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

8157757

1 reference